Tapio, S. ; Little, M.P.* ; Kaiser, J.C. ; Impens, N.* ; Hamada, N.* ; Georgakilas, A.G.* ; Simar, D.* ; Salomaa, S.*
Ionizing radiation-induced circulatory and metabolic diseases.
Environ. Int. 146:106235 (2021)
Risks to health are the prime consideration in all human situations of ionizing radiation exposure and therefore of relevance to radiation protection in all occupational, medical, and public exposure situations. Over the past few decades, advances in therapeutic strategies have led to significant improvements in cancer survival rates. However, a wide range of long-term complications have been reported in cancer survivors, in particular circulatory diseases and their major risk factors, metabolic diseases. However, at lower levels of exposure, the evidence is less clear. Under real-life exposure scenarios, including radiotherapy, radiation effects in the whole organism will be determined mainly by the response of normal tissues receiving relatively low doses, and will be mediated and moderated by systemic effects. Therefore, there is an urgent need for further research on the impact of low-dose radiation. In this article, we review radiation-associated risks of circulatory and metabolic diseases in clinical, occupational or environmental exposure situations, addressing epidemiological, biological, risk modelling, and systems biology aspects, highlight the gaps in knowledge and discuss future directions to address these gaps.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Circulatory Disease ; Endothelial ; Heart ; Ionizing Radiation ; Metabolic Syndrome ; Radiotherapy ; Systems Biology; Acute Lymphoblastic-leukemia; Ischemic-heart-disease; Intima-media Thickness; Long-term Survivors; Inflammatory Plaque Phenotype; Childhood-cancer Survivors; Genome-wide Association; Dose-escalation Trials; Atomic-bomb Survivors; Body-mass-index
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
2020
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
0160-4120
e-ISSN
1873-6750
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 146,
Heft: ,
Seiten: ,
Artikelnummer: 106235
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
The Boulevard, Langford Lane, Kidlington, Oxford Ox5 1gb, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30202 - Environmental Health
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Radiation Sciences
PSP-Element(e)
G-500200-001
G-501391-001
Förderungen
National Cancer Institute
National Institutes of Health
Division of Cancer Epidemiology and Genetics, National Cancer Institute
Copyright
Erfassungsdatum
2020-12-09